Endocare Secures Funding to Expand Personalised Metabolic Health Across Middle East

Editorial Team

Last updated 8-05-2025

2 min

Endocare, a Dubai-based clinic, closed a new funding round to expand in the Middle East.

They specialise in obesity management and metabolic health through personalised medical and lifestyle interventions.

RbetaQ Holding, a German family office, led the investment to support innovative healthcare solutions.

Dr Ashok Kaul joins the board, bringing expertise in data science and artificial intelligence.

Endocare's expansion aims to meet the rising demand for effective, personalised health strategies in Dubai.

There's some fresh and exciting news coming from the UAE's healthcare sector. Endocare—a Dubai-based clinic dedicated to providing specialised metabolic health solutions—has just successfully closed a new round of funding. They're clearly buzzing with ambitious plans to expand their impact across the Middle East, particularly targeting the UAE and Saudi Arabia.

Endocare, founded by Leyla Azizova, Janik Schmalhorst, and Dr. Hisham Harb, has quickly made a name for itself by focusing heavily on managing obesity and improving metabolic health through a personalised approach. Blending medical hormone therapies alongside tailored lifestyle interventions—like nutrition advice, exercise routines, better sleep habits, and stress management techniques—the clinic offers an integrative care model designed not only to help shed pounds but also to promote sustained health in the long run.

Driving this recent investment round was RbetaQ Holding, a prominent family office headquartered in Germany, known for backing cutting-edge healthcare and tech initiatives. Clearly, they share Endocare’s enthusiasm for providing innovative and sustainable healthcare solutions; it's safe to say Endocare's ambitions align quite perfectly with growing regional demand.

And there certainly seems to be plenty of appetite locally—pun definetely intended—for effective weight-loss and metabolic health strategies. Dubai residents in particular have become increasingly health-conscious, looking not just for quick fixes but for long-term, personalised and scientifically-backed approaches. Endocare aims exactly at meeting this rising demand head-on.

Alongside the exciting funding news, the company has brought aboard an impressive new addition to their board—Dr. Ashok Kaul. Dr. Kaul’s vast experience in fields like data science, tech, and artificial intelligence is expected to add tremendous value, steering Endocare into fresh, tech-driven territory and enhancing patient care.

With this latest round of funding and fresh talent joining the team, Endocare looks set to make waves in the region’s healthcare scene. For readers of Arageek and others keeping tabs on innovative healthcare solutions emerging from the Gulf, this certainly feels like one to watch.

🚀 Got exciting news to share?

If you're a startup founder, VC, or PR agency with big updates—funding rounds, product launches 📢, or company milestones 🎉 — AraGeek English wants to hear from you!